AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29

Authors: Pieber, D Allport, VC Hills, F Johnson, M Bennett, PR
Citation: D. Pieber et al., Interactions between progesterone receptor isoforms in myometrial cells inhuman labour, MOL HUM REP, 7(9), 2001, pp. 875-879

Authors: Elliott, CL Allport, VC Loudon, JAZ Wu, GD Bennett, PR
Citation: Cl. Elliott et al., Nuclear factor-kappa B is essential for up-regulation of interleukin-8 expression in human amnion and cervical epithelial cells, MOL HUM REP, 7(8), 2001, pp. 787-790

Authors: Allport, VC Pieber, D Slater, DM Newton, R White, JO Bennett, PR
Citation: Vc. Allport et al., Human labour is associated with nuclear factor-kappa B activity which mediates cyclo-oxygenase-2 expression and is involved with the 'functional progesterone withdrawal', MOL HUM REP, 7(6), 2001, pp. 581-586

Authors: Elliott, CL Loudon, JAZ Brown, N Slater, DM Bennett, PR Sullivan, MHF
Citation: Cl. Elliott et al., IL-1 beta and IL-8 in human fetal membranes: Changes with gestational age,labor, and culture conditions, AM J REPROD, 46(4), 2001, pp. 260-267

Authors: Welsh, AW Bennett, PR Fisk, NM
Citation: Aw. Welsh et al., Quantitative digital analysis of regional placental perfusion using power Doppler in placental abruption, ULTRASOUN O, 17(3), 2001, pp. 203-208

Authors: Campagnoli, C Roberts, I Kumar, S Bennett, PR Fisk, NM
Citation: C. Campagnoli et al., Clonal culture of fetal cells from maternal blood, LANCET, 357(9260), 2001, pp. 962-962

Authors: Pieber, D Allport, VC Bennett, PR
Citation: D. Pieber et al., Progesterone receptor isoform A inhibits isoform B-mediated transactivation in human amnion, EUR J PHARM, 427(1), 2001, pp. 7-11

Authors: Campagnoli, C Roberts, IAG Kumar, S Bennett, PR Bellantuono, I Fisk, NM
Citation: C. Campagnoli et al., Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow, BLOOD, 98(8), 2001, pp. 2396-2402

Authors: Choolani, M O'Donnell, H Campagnoli, C Kumar, S Roberts, I Bennett, PR Fisk, NM
Citation: M. Choolani et al., Simultaneous fetal cell identification and diagnosis by epsilon-globin chain immunophenotyping and chromosomal fluorescence in situ hybridization, BLOOD, 98(3), 2001, pp. 554-557

Authors: Groom, KM Bennett, PR Shennan, AH
Citation: Km. Groom et al., Randomised, double-blind, placebo controlled pilot study assessing nitroglycerin as a tocolytic, BR J OBST G, 107(9), 2000, pp. 1182-1182

Authors: Allport, VC Slater, DM Newton, R Bennett, PR
Citation: Vc. Allport et al., NF-kappa B and AP-1 are required for cyclo-oxygenase 2 gene expression in amnion epithelial cell line (WISH), MOL HUM REP, 6(6), 2000, pp. 561-565

Authors: Fisk, NM Bennett, PR
Citation: Nm. Fisk et Pr. Bennett, Hypothesis testing by X chromosome inactivation patterns may be more informative with lineage-specific cells, MOL HUM REP, 6(2), 2000, pp. 197-198

Authors: Elliott, CL Slater, DM Dennes, W Poston, L Bennett, PR
Citation: Cl. Elliott et al., Interleukin 8 expression in human myometrium: Changes in relation to laboronset and with gestational age, AM J REPROD, 43(5), 2000, pp. 272-277

Authors: Houfflin-Debarge, V O'Donnell, H Overton, T Bennett, PR Fisk, NM
Citation: V. Houfflin-debarge et al., High sensitivity of fetal DNA in plasma compared to serum and nucleated cells using unnested PCR in maternal blood, FETAL DIAGN, 15(2), 2000, pp. 102-107

Authors: Sawdy, RJ Slater, DM Dennes, WJB Sullivan, MHF Bennett, PR
Citation: Rj. Sawdy et al., The roles of the cyclo-oxygenases types one and two in prostaglandin synthesis in human fetal membranes at term, PLACENTA, 21(1), 2000, pp. 54-57

Authors: Brown, NL Alvi, SA Elder, MG Bennett, PR Sullivan, MHF
Citation: Nl. Brown et al., The regulation of prostaglandin output from term intact fetal membranes byanti-inflammatory cytokines, IMMUNOLOGY, 99(1), 2000, pp. 124-133

Authors: Slater, DM Dennes, WJB Campa, JS Poston, L Bennett, PR
Citation: Dm. Slater et al., Expression of cyclo-oxygenase types-1 and-2 in human myometrium throughoutpregnancy, MOL HUM REP, 5(9), 1999, pp. 880-884

Authors: Brown, NL Slater, DM Alvi, SA Elder, MG Sullivan, MHF Bennett, PR
Citation: Nl. Brown et al., Expression of 5-lipoxygenase and 5-lipoxygenase-activating protein in human fetal membranes throughout pregnancy and at term, MOL HUM REP, 5(7), 1999, pp. 668-674

Authors: Alvi, SA Brown, NL Bennett, PR Elder, MG Sullivan, MHF
Citation: Sa. Alvi et al., Corticotrophin-releasing hormone and platelet-activating factor induce transcription of the type-2 cyclo-oxygenase gene in human fetal membranes, MOL HUM REP, 5(5), 1999, pp. 476-480

Authors: Fisk, NM Howard, C Ware, M Bennett, PR
Citation: Nm. Fisk et al., X-chromosome inactivation patterns do not implicate asymmetric splitting of the inner cell mass in the aetiology of twin-twin transfusion syndrome, MOL HUM REP, 5(1), 1999, pp. 52-56

Authors: Cirignano, L Shah, KS Bennett, PR Klugerman, M Dmitryev, Y Squillante, MR Narita, T Bloser, P Grindlay, J Hasegawa, BH Iwata, K
Citation: L. Cirignano et al., Pixellated CdZnTe detector for emission/transmission computed tomography, NUCL INST A, 422(1-3), 1999, pp. 216-220

Authors: Iwata, K Hasegawa, BH Heanue, JA Bennett, PR Shah, KS Boles, CD Boser, BE
Citation: K. Iwata et al., CdZnTe detector for combined x-ray CT and SPECT, NUCL INST A, 422(1-3), 1999, pp. 740-744

Authors: Sawdy, RJ Dennes, WJB Allport, V Slater, DM Elder, MG Sullivan, MHF Bennett, PR
Citation: Rj. Sawdy et al., Region and labour-dependent synthesis of prostaglandin E2 by human fetal membranes, PLACENTA, 20(2-3), 1999, pp. 181-184

Authors: Bartlett, SR Bennett, PR Campa, JS Dennes, WJB Slater, DM Mann, GE Poston, L Poston, R
Citation: Sr. Bartlett et al., Expression of nitric oxide synthase isoforms in pregnant human myometrium, J PHYSL LON, 521(3), 1999, pp. 705-716

Authors: Alvi, SA Rajasingam, D Brown, NL Elder, MG Bennett, PR Sullivan, MHF
Citation: Sa. Alvi et al., The production of interleukin-1 beta from human fetal membranes is not obligatory for increased prostaglandin output, IMMUNOLOGY, 97(2), 1999, pp. 249-256
Risultati: 1-25 | 26-29